Barclays’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Buy |
442,979
+248,350
| +128% | +$518K | ﹤0.01% | 2711 |
|
|
2025
Q1 | $332K | Sell |
194,629
-31,637
| -14% | -$54K | ﹤0.01% | 3070 |
|
|
2024
Q4 | $1.14M | Sell |
226,266
-10,476
| -4% | -$52.9K | ﹤0.01% | 2555 |
|
|
2024
Q3 | $1.29M | Buy |
236,742
+151,458
| +178% | +$824K | ﹤0.01% | 2461 |
|
|
2024
Q2 | $409K | Buy |
85,284
+18,319
| +27% | +$87.9K | ﹤0.01% | 2645 |
|
|
2024
Q1 | $208K | Sell |
66,965
-30,222
| -31% | -$93.9K | ﹤0.01% | 3319 |
|
|
2023
Q4 | $276K | Buy |
97,187
+73,399
| +309% | +$208K | ﹤0.01% | 3362 |
|
|
2023
Q3 | $70K | Sell |
23,788
-47,055
| -66% | -$138K | ﹤0.01% | 3453 |
|
|
2023
Q2 | $203K | Buy |
70,843
+26,591
| +60% | +$76.2K | ﹤0.01% | 3071 |
|
|
2023
Q1 | $136K | Buy |
44,252
+14,145
| +47% | +$43.5K | ﹤0.01% | 3364 |
|
|
2022
Q4 | $63K | Buy |
30,107
+15,036
| +100% | +$31.5K | ﹤0.01% | 3689 |
|
|
2022
Q3 | $49K | Sell |
15,071
-137
| -0.9% | -$445 | ﹤0.01% | 3661 |
|
|
2022
Q2 | $49K | Buy |
15,208
+647
| +4% | +$2.09K | ﹤0.01% | 3735 |
|
|
2022
Q1 | $103K | Buy |
+14,561
| New | +$103K | ﹤0.01% | 3651 |
|